Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers
Clinical trial NCT03806686 · UNKNOWN
Trial details
- NCT number
- NCT03806686
- Sponsor
- Quratis Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2020-03-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.